Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$591,341
-$24,396 QoQ
Shares Held
1,633
-6.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#2,063
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Weaver Consulting Group holds $4,407,808 across 7 Drug Manufacturers - General names. AMGN ranks #4 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,013 | $1,273,151 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
6,077 | $767,768 | |
| 3 | LLY |
ELI LILLY & Co
|
551 | $660,885 | |
| 4 | AMGN |
Amgen Inc
This page
|
1,633 | $591,341 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,026 | $517,341 | |
| 6 | ABBV |
AbbVie Inc.
|
1,228 | $309,013 | |
| 7 | PFE |
Pfizer Inc
|
11,973 | $288,309 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $591,341 | 1,633 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $615,737 | 1,750 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $588,830 | 1,799 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $478,611 | 1,696 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $472,423 | 1,692 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $522,157 | 1,676 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $427,710 | 1,641 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $530,357 | 1,646 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $514,292 | 1,646 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $467,990 | 1,646 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $502,882 | 1,746 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $478,661 | 1,781 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $373,215 | 1,681 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $406,381 | 1,681 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $464,347 | 1,768 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $398,507 | 1,768 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $430,154 | 1,768 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $405,532 | 1,677 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $384,023 | 1,707 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $340,665 | 1,602 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $379,518 | 1,557 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $305,538 | 1,228 | Shares | Sole | 2021-04-07 | |
| 2020-12-31 | $289,699 | 1,260 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $320,241 | 1,260 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $297,183 | 1,260 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $255,439 | 1,260 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||